NCT01246336
Completed
Not Applicable
Exploratory Study to Detect Volatile Biomarkers of Idiopathic Parkinson's Disease and Parkinsonism From Exhaled Breath Using a Nanomedical Artificial Olfactory System.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson's Disease
- Sponsor
- Rambam Health Care Campus
- Enrollment
- 41
- Primary Endpoint
- Nanosensory detection
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.
Investigators
Ilana Schlesinger
Ilana Schleainger, Rambam Health Care Campus
Rambam Health Care Campus
Eligibility Criteria
Inclusion Criteria
- •Patients with Parkinsonism
Exclusion Criteria
- •Severe dementia
Outcomes
Primary Outcomes
Nanosensory detection
Time Frame: immediate
analyze combinations of nanomaterial-based sensors (organically functionalized carbon nanotubes and gold nanoparticles)
Similar Trials
Unknown
Not Applicable
Biomarker Analysis for GBA Associated Parkinson's DiseaseParkinson DiseaseGaucher DiseaseNCT03811496Lysosomal and Rare Disorders Research and Treatment Center, Inc.100
Recruiting
Not Applicable
Biomarkers in Parkinsonian SyndromesParkinson DiseaseProgressive Supranuclear PalsyMultiple System AtrophyAtypical ParkinsonismParkinsonismNCT06501469Non-profit organization for scientific research in Parkinson's disease and related disorders200
Recruiting
Not Applicable
Serum Biomarkers in Parkinson's Disease at Different StagesParkinson DiseaseNCT05769699Fondazione Policlinico Universitario Agostino Gemelli IRCCS200
Recruiting
Not Applicable
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using NeuroimagingParkinson DiseaseMultiple System AtrophyProgressive Supranuclear PalsyNCT03872102University of Texas Southwestern Medical Center90
Recruiting
Not Applicable
Biomarkers for differentiation of Parkinson*s disease subtypes.Parkinson's10028037NL-OMON39292eids Universitair Medisch Centrum210